When the Cass Review came out, the UK put a pause on the National Health Service’s use of puberty blockers to “transition” children to treat gender dysphoria.
The original pause only applied to the NHS, so private and foreign providers could still prescribe these dangerous drugs to children.
Not anymore. Puberty blockers are now banned for the treatment of gender dysphoria. Period. Full stop.
This ban specifically addresses the UK-registered private providers as well as overseas suppliers, since NHS England has already stopped the PB use to treat gender dysphoria per its updated policy. The PB trial will begin recruiting patients in April. /2https://t.co/66oxDlCE0y
— SEGM (@segm_ebm) December 11, 2024
It’s no surprise that these drugs are dangerous. They were originally designed to be used in the treatment of cancer and have been used to chemically…
